awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30730505-91FA8E6C-2DF0-486F-8BF2-627D7344E6CD
Q30730505-91FA8E6C-2DF0-486F-8BF2-627D7344E6CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30730505-91FA8E6C-2DF0-486F-8BF2-627D7344E6CD
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
P2860
Q30730505-91FA8E6C-2DF0-486F-8BF2-627D7344E6CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30730505-91FA8E6C-2DF0-486F-8BF2-627D7344E6CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c4cb7842cfd07d27ee5e9e570f8fb316b6c1edd
P2860
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.